Lexapro, known generically as escitalopram, was first approved by the U.S. Food and Drug Administration (FDA) in 2002 [1].
How is Lexapro approved and marketed?
Lexapro is an antidepressant medication belonging to the class of drugs known as selective serotonin reuptake inhibitors (SSRIs). It is prescribed to treat major depressive disorder and generalized anxiety disorder [2]. The drug is marketed by Lundbeck and Takeda Pharmaceuticals [3].
What are the patent and exclusivity details for Lexapro?
The primary patents protecting Lexapro have expired, allowing for the development and marketing of generic versions. According to DrugPatentWatch.com, the innovator patent for escitalopram expired in 2015 [4]. Patent expiry allows generic manufacturers to produce and sell their own versions of the drug, often leading to lower prices [5].
When can generic versions of Lexapro be expected?
With the expiration of key patents, generic versions of Lexapro are already available on the market. The availability of generics typically begins soon after patent expiry, subject to regulatory approvals for the generic products [4][5].
What are the clinical uses of Lexapro?
Lexapro is used to treat symptoms of depression, including persistent sadness, loss of interest, and changes in sleep or appetite. It is also used for generalized anxiety disorder, characterized by excessive worry and tension [2].
Are there any alternatives to Lexapro?
As an SSRI, Lexapro is one of several options for treating depression and anxiety. Other SSRIs, such as fluoxetine (Prozac) and sertraline (Zoloft), are also commonly prescribed. Other classes of antidepressants, like serotonin-norepinephrine reuptake inhibitors (SNRIs) and atypical antidepressants, may also be considered depending on individual patient needs and responses [6].
What are the potential side effects of Lexapro?
Common side effects associated with Lexapro can include nausea, insomnia, ejaculation disorder, fatigue, and increased sweating [2]. Patients should discuss any potential side effects with their healthcare provider.
Sources:
1. https://www.accessdata.fda.gov/scripts/cder/daf/index.cfm?event=overview.process&ApplNo=021074
2. https://www.rxlist.com/lexapro-drug.htm
3. https://www.drugpatentwatch.com/
4. https://www.drugpatentwatch.com/lexapro-patent-information
5. https://www.fda.gov/drugs/generic-drugs/what-generic-drug-and-how-does-it-work
6. https://www.nimh.nih.gov/health/topics/depression/treatment-for-depression